Erratum: In vivo activation of a mutant μ-opioid receptor by antagonist: Future direction for opiate pain treatment paradigm that lacks undesirable side effects (Proceedings of the National Academy of Sciences of the United States of America (February 18, 2003) 100:4 (2117-2121))